Symposia

INDUSTRY SYMPOSIA

AUDITORIUM / LEVEL -1

THURSDAY JANUARY 23

16.00

Symposium


Achieving durable EVAR
Clinical considerations and real-world results with the Cook Zenith platform

-The French multicenter post-market thoracic study, Ludovic Berger
-AAA European guidelines and the impact of indications on durable outcomes. Long-term experience with the Cook AAA devices, Stephan Haulon

17.40

Symposium


Moderator: Jean Pierre BECQUEMIN
Aortic arch FET treatment using Thoraflex™ hybrid
The surgical hybrid stent graft
-Epiflex French registry: rational and sequential analysis of early outcomes: T. Caus
-FET, multidisciplinary approach, Pre, Per and Post procedure: X. Chaufour
-FET, HEGP Paris results: C. H. Gautier

FRIDAY JANUARY 24

10.50

Symposium


AC regression driver of EVAR long term outcome, a new paradigm shift
Moderators: J. Busquet & S. Haulon
-Endurant long term performance: results from trials and technical aspects, J. P. Becquemin
-How to maintain high sac regression rates in hostile necks: the role of endoanchors, A. Millon
-Type II EL: how to minimize a contributing factor to failure to regress, D. Fabre

11.40

Symposium


Moderator: Stephan Haulon
-Bridging stents in FEVAR, what is the key to success, Blandine Maurel
-Bare or covered stents, when to use what for Iliac occlusive disease? Xavier Chaufour
-Covered stents as a problem solver for endovascular emergencies, Maria Antonella Ruffino

14.40

Symposium


Paclitaxel: for whom and why do I use drug eluting technologies?
Moderator: Stephan HAULON
-DCB : studies, experience & recommendations, Raphaël COSCAS
-DES : studies, experience & recommendations, Yann GOUEFFIC
-DES: my experience since meta-analysis, Gilles GOYAULT

15.30

Symposium


Treatment of femoral popliteal lesions: a cornelian dilemma
Moderator: Jean-Pierre Becquemin
-Clinical cases presentation, Yann Gouëffic
-Which one of us is the most innovative? Eric Ducasse vs Raphael Coscas

SATURDAY JANUARY 25

09.50

Symposium


GORE® VIABAHN® endoprosthesis demonstrates powerful patency in 20+ cm SFA Lesions
Modérateur : Yann Goueffic
-Femoropopliteal bypasses with heparin-bonded PTFE are a durable treatment for long SFA-popliteal occlusions: when they are the best treatment and why, Nellie Della Schiava
-How to achieve good results with GORE® VIABAHN® endoprosthesis for treating complex femoropopliteal occlusive disease – clinical cases, Bertrand Saint Lebes
-Discussion animated by Yann Goueffic

11.30

Symposium


Published Lutonix® safety data and the value of the Ultrascore™ device:
Moderator: Eric Ducasse
-Lutonix®  clinical program overview and published independent safety analysis results: Y. Goueffic
-How low pressure inflation with scoring technologies better preserves the vessel and increases revascularization success: R. Langhoff

INDUSTRY SYMPOSIA

ROOM B / LEVEL 0

FRIDAY JANUARY 24

12.00

Symposium


First WavelinQ Patients in Bordeaux, Eric Ducasse
Covera stent “safe and effective” at treating failing arteriovenous access,
Sameh Awad

Simultaneous translation:

Headphones will be available on request
(only if a valid ID is presented) when entering the room.